HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): John E. Mayer, Jr. Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gentles, T. L. Articles by Wernovsky, G. Search for Related Content PubMed PubMed Citation Articles by Gentles, T. L. Articles by Wernovsky, G.

J Thorac Cardiovasc Surg 1997;114:392-403
© 1997 Mosby, Inc.

SURGERY FOR CONGENITAL HEART DISEASE

FUNCTIONAL OUTCOME AFTER THE FONTAN OPERATION: FACTORS INFLUENCING LATE MORBIDITY

K.G. was supported in part by the Kobren Fund.

Received for publication Nov. 5, 1996; revisions requested Jan. 22, 1997 revisions received June 2, 1997; accepted for publication June 2, 1997. Address for reprints: Jane Newburger, MD, Department of Cardiology, Children's Hospital, 300 Longwood Ave., Boston, MA 02115.

Abstract

Objectives: The purpose of this study was to describe the functional outcome of a large number of patients after modifications of the Fontan operation and to investigate perioperative risk factors that might influence late functional state. Methods: A comprehensive cross-sectional review of the first 500 patients undergoing a Fontan operation at our institution was undertaken. Those surviving with an intact Fontan circulation were reviewed by questionnaire to assess functional status and medication history. Medical records, chest roentgenograms, echocardiograms, cardiac catheterizations, and laboratory investigations were also reviewed to assess postoperative status. Results: Three hundred sixty-three long-term survivors with an intact Fontan circulation were identified during cross-sectional follow-up. Median age at operation was 5.0 years (range 0.4 to 31 years), and median follow-up was 5.4 years (range 1.7 to 20 years). Most patients (91.1%) were in New York Heart Association class I or II. In a multivariate model, poor (class III or IV) functional state was associated with longer duration of follow-up ( p < 0.001), a prior atrial septectomy ( p = 0.03), and a prior main pulmonary artery-ascending aorta anastomosis ( p = 0.05). Conclusions: A poor functional outcome is uncommon after the Fontan operation but becomes more frequent with increasing duration of follow-up.

Over the past 20 years the early operative outcome after the Fontan operation has improved markedly. ^1-5 As more patients survive the operation, attention is being drawn to the late sequelae of the Fontan circulation. Recent reports have emphasized a continuing risk of late failure ^5-7 and a poor functional outcome in some long-term survivors. ^6,7 Exercise capacity is reduced, ⁸ atrial arrhythmias are common, ^9,10 some patients may have neurologic or cognitive deficits, ¹¹ and protein-losing enteropathy can be debilitating. ¹² Increasing numbers of these patients with poor functional outcome are being referred for cardiac transplantation. ⁵

The purpose of this study was to describe the functional outcome of a large number of patients after various modifications of the Fontan operation and to assess perioperative risk factors affecting outcome in this patient population.

Methods

Subjects.
The first 500 patients who underwent various modifications of the Fontan procedure at Children's Hospital, Boston, were identified. The date of the operation ranged from April 1973 to July 1991, and cross-sectional follow-up of survivors was undertaken between September 1992 and July 1994. Patients who had died or had undergone cardiac transplantation or takedown of their Fontan circulation to a bidirectional cavopulmonary shunt or an aortopulmonary shunt before the cross-sectional study period were excluded from this analysis. An analysis of patient-and procedure-related risk factors influencing early and late failure is the subject of a separate report. ⁵

Patient contact.
Records of the Departments of Cardiology and Cardiac Surgery of Children's Hospital, Boston. were reviewed and referring centers were contacted. Each patient's current status (alive with a Fontan circulation or otherwise) was thus verified and his or her most recent known address obtained. A questionnaire addressing medication use, medical history, functional state, employment, and insurance status was sent to each surviving patient. If the questionnaire was not returned within 30 days, a second questionnaire was sent, and if this was not returned attempts were made to contact the patient by telephone. If the patient could not be contacted by these means, attempts were made to verify the address and, when necessary, the process was repeated. The study was approved by our institutional review board on August 18, 1992.

Perioperative variables.
Medical records, preoperative echocardiographic and cardiac catheterization data, and operation notes were reviewed to obtain the perioperative data outlined in Appendix A.

Outcome measurements.
The following outcome indices were obtained.

Subjective data.
Age-specific functional data were obtained from the questionnaire and the referring physician, and a New York Heart Association (NYHA) classification of functional status was derived by consensus of three of the authors (T.L.G., S.B.F., and G.W.). The presence of protein-losing enteropathy or liver disease was confirmed by review of the medical records or by contact with the referring physician.

Objective tests.
Records were reviewed for the results of the following assessments obtained during the cross-sectional follow-up period: physical examination, chest roentgenogram, and serum liver function tests.

Results of all echocardiograms or cardiac catheterizations after the Fontan operation were recorded (Appendixes B and C). Twelve-lead and ambulatory electrocardiograms and neurologic and psychologic examinations were also undertaken and are the subjects of separate reports. ^10,13 In patients who were not evaluated at our institution, the aforementioned information was obtained from the referring physician.

Statistical analysis.
Some outcome measures were not available for all patients. Thus, to determine the extent to which selection bias might have influenced the results, we used the Wilcoxon rank sum test, two-sample t test, or ² test, as appropriate, to compare perioperative data for the subset of patients who had the outcome measure with data for those who did not. The primary outcome of interest, NYHA classification of functional status, was assigned from questionnaire data or physician correspondence, or both. This outcome was then collapsed to form two groups, "good" functional status (class I or II) and "poor" functional status (class III or IV). Relationships with perioperative variables were evaluated by means of contingency table methods and logistic regression analysis. When multivariate models were being constructed, a p value of 0.05 was required for retention in the model. Potential interactions among variables included in the model were examined.

Results

Patient population.
Of the 500 patients, 416 (83.2%) survived the early postoperative period with their Fontan circulation intact. During the cross-sectional follow-up period, 398 patients (95.7%) were accounted for; six were lost to follow-up after hospital discharge and a further 12 patients, known to be alive with a Fontan circulation 1.7 to 9.7 years after the Fontan operation, could not be traced.

A total of 35 late failures occurred (defined as death, takedown of the Fontan circulation to an aortopulmonary or cavopulmonary shunt, or cardiac transplantation) in a total of 2464 patient-years of follow-up (1.42 per 100 patient-years). One additional failure occurred late in the cross-sectional follow-up period; inasmuch as data collection for this individual had been completed before the failure, the information obtained has been included in the following analyses. Hence 363 of 381 potential long-term survivors (95.3%) with an intact Fontan circulation were identified during the cross-sectional review period (Fig. 1). No significant differences were noted between these 363 patients and the 18 patients lost to follow-up, except that those lost to follow-up were less likely to have had a baffle fenestration (1/18 [5.6%] vs 125/363 [34.4%], p = 0.01).

View larger version (16K): [in this window] [in a new window]   Fig. 1. Outcome in the 500 study patients.* An additional late failure occurred late in the cross-sectional follow-up period. Inasmuch as data collection for this individual had been completed before the failure, this patient has been included in the study group (see text for details).

Reintervention.
Of the 363 patients, 75 (20.1%) underwent 113 late reoperations (>30 days after the modified Fontan operation) and 88 patients (24.2%) underwent 128 transcatheter procedures, with an overall reintervention rate of 10.1 per 100 patient-years (Appendix D). Thirty-four patients (9.4%) had pacemakers implanted, four before the Fontan operation and 30 after.

Examination characteristics.
Height and weight measurements were available in 219 patients. No significant differences were noted in patient-or procedure-related risk factors or in postoperative functional status between those for whom these data were available and those for whom they were not available. Measurements were standardized with respect to age by subtracting the age-specific mean for the normal population and dividing by the standard deviation to create Z-scores. Height was more than two standard deviations below the normal population mean in 30 patients (13.7%) and weight in 13 patients (5.9%). Overall, the mean height and weight Z-scores were significantly lower than those of a normal population (-0.6 ± 1.3 and -0.3 ± 1.2, respectively; p < 0.001 for both). However, when compared with preoperative values, a significant increase was observed in both height and weight at follow-up (p < 0.001 for both), indicating catch-up growth had occurred after the Fontan operation (Fig. 2) Transcutaneous oximetry was available in 127 patients. The mean oximetry saturation was 93.1% ± 4.1% and ranged from 80%, in a patient with pulmonary vein stenosis and a baffle fenestration, to 100%. A significant difference was noted between oximetry saturations in patients with an open baffle fenestration (85.1% ± 2.3%) and those with no baffle fenestration (93.6% ± 3.4%) or with a baffle fenestration that had been closed (94.7% ± 2.7%, p < 0.001). Other examination findings and chest roentgenographic findings are summarized in Tables II and III.

View larger version (18K): [in this window] [in a new window]   Fig. 2. Box plots of preoperative and postoperative weight and height Z-scores. The central box extends from the 25th percentile to the 75th percentile; the center line marks the 50th percentile (median). The lines projecting from the box encompass the range of the data, excepting outlying values, which are represented by circles.

Functional state.
Current health was reported as excellent or good by 283 of 310 respondents (91.3%), fair by 26 (8.4%), and poor by one (0.3%). The questionnaire responses to an age-specific assessment of functional state are summarized in Table IV.

Medications.
A medication history was obtained in 327 patients (90.1%). One hundred twenty-four (37.9%) were receiving no cardiac medications, and 31 (9.5%) were receiving four or more cardiac medications. Antiarrhythmic medication (other than digoxin) was taken by 36 (11.0%) (Fig. 3).

View larger version (90K): [in this window] [in a new window]   Fig. 3. A, Number of medications per patient. B, Type of medications (many patients were receiving more than one type of medication). *Antiarrhythmic medication other than digoxin.

Synthetic liver function.
Serum albumin was below the normal range (< 3.4 gm/L) in four of 92 patients (4.3%) for whom data were available: all four had symptomatic protein-losing enteropathy. The prothrombin time was available in 67 patients (excluding those receiving warfarin). It was normal (<12.5 seconds) in 28 patients (41.8%), mildly elevated (12.5 to 13.5 seconds) in 36 patients (53.7%), and markedly elevated (14 seconds) in three patients (4.5%), one of whom had protein-losing enteropathy. The international normalized ratio was not systematically recorded.

Enzymatic liver function.
Measurements of serum transaminases (aspartate transaminase or alanine transaminase) were available in 97 patients and were within normal limits in four (4.1%), mildly elevated (less than twice the upper limit of normal) in 86 (88.7%), moderately elevated (two to three times the upper limit of normal) in five (5.2%), and severely elevated (more than three times the upper limit of normal) in two patients (2.1%). No patient is known to have cirrhosis, but one individual with serologic evidence of previous hepatitis C infection has chronic active hepatitis.

Protein-losing enteropathy.
Protein-losing enteropathy, defined as persistent hypoalbuminemia (<3.0 mg/dl) in the absence of liver or renal disease, with accompanying clinical features including abdominal pain, diarrhea, edema, and ascites, was present in nine of the 363 patients (2.5%) traced during the cross-sectional follow-up period. An additional two patients whose Fontan circulations failed before the cross-sectional follow-up period were known to have protein-losing enteropathy. Hence protein-losing enteropathy developed in 11 of the 416 early survivors (2.6%) with an intact Fontan circulation, a rate of 0.45 cases per 100 patient-years.

Discussion

This study details the functional status of a large number of patients who underwent the Fontan operation over a period that encompassed many changes in preoperative management and operative technique. The majority of patients (more than 90%) perceived their state of health to be good or excellent and were able to partake in most of the activities of daily living. Most adults were either employed or continuing tertiary education, a finding similar to that reported by Mair, Puga, and Danielson. ¹⁵ Nevertheless, cardiac medication use was common, and reintervention was frequent. Furthermore, a small group of patients were more severely limited and, disturbingly, the incidence of limitation appeared to be related to length of follow-up. Because duration of follow-up in this cohort is closely related to age at follow-up, date of operation, age at operation, and type of operation, it is not possible to be certain as to the cause of the poorer functional state of patients followed up for longer periods. In addition, the perception of limitation and expectations alter with age; limitations are less apparent to the parents and family of young children than they are to adolescents and adults. Nir and coworkers ¹⁶ found no deterioration in serial exercise tests in a small group of patients after the Fontan operation, suggesting that changing expectations may be an important factor.

Procedural variables including a history of prior atrial septectomy, main pulmonary artery-ascending aorta anastomosis, or ventricular septal defect enlargement were also associated with a poor functional state. These procedures are common in patients with left-sided atrioventricular valve atresia or stenosis, left ventricular hypoplasia, and obstruction of the systemic outflow tract. We have also found these anatomic subgroups to be associated with a higher risk of early and late failure of the Fontan circulation. ⁵ Reasons for the poorer outcome in these subgroups are speculative and probably multiple. Ventricular hypertrophy exacerbated by outflow tract obstruction may impair diastolic function and thus increase central venous pressure. ¹⁷ Only three patients in this series had ventricular septal defect enlargement; thus it is unlikely that ventricular dysfunction resulting from myocardial resection is a contributing cause. However, many did have hypoplastic left heart syndrome, an anatomic subtype particularly at risk for ventricular dysfunction as a result of ventricular morphology, coronary artery anomalies, extensive palliative procedures in early infancy, or residual arch obstruction.

Neither the presence nor absence of a baffle fenestration was related to functional outcome. Although numbers are small—only 23 patients had an open fenestration at follow-up—these findings suggest that mild arterial desaturation is well tolerated. Fenestration closure frequently results in a fall in resting cardiac output and an increase in systemic venous pressure. ¹⁸ Furthermore, it is possible that the ability to increase cardiac output with exercise is enhanced when a patent fenestration is in place. A study of cardiorespiratory exercise capacity before and after fenestration closure would clarify this issue.

Driscoll and colleagues ⁷ have identified heterotaxy as a risk factor for death and for a poor functional outcome in survivors. Although heterotaxy syndrome was not a risk factor for poor functional outcome in the current series, we ⁵ have found it to be a predictor of late failure of the Fontan circulation; many patients with heterotaxy syndrome had Fontan failure before the cross-sectional review and therefore could not be included in an analysis of late functional outcome.

Atrial arrhythmias, especially sinus node dysfunction and atrial flutter, are an important cause of morbidity after the Fontan operation. A significant minority of patients in the current series were receiving antiarrhythmic medication or had undergone pacemaker implantation. Using the same patient cohort, we ¹⁰ have previously demonstrated that atrial flutter was less likely to occur in patients in NYHA class I (10%) than in those with class II or class III symptoms (21% and 26%, respectively, p = 0.02). In addition, the atrial flutter became more prevalent with increasing duration of follow-up; the probability of freedom from atrial flutter was 94.6% at 2 years, 89.7% at 5 years, and 67.7% at 10 years. Atrial arrhythmias may well have contributed to the association between poor functional outcome and duration of follow-up in the current series.

Although height and weight were lower than those of the normal population, the group as a whole exhibited "catch-up" growth after the Fontan operation. This suggests that many patients had a more favorable hemodynamic state after the operation than before; chronic preoperative cyanosis and congestive heart failure may have a greater impact on growth than the elevated central venous pressure and low-normal cardiac output after the Fontan operation. Neurologic, psychologic, and developmental abnormalities are another important cause of morbidity in this patient group. A detailed investigation in a subgroup of this cohort is the subject of a separate report. ¹⁹

Laboratory investigations.
Minor abnormalities in serum liver function tests were common. Others have reported a small but important incidence of cirrhosis after the Fontan operation. ⁷ Our study population included no patients with cirrhosis, but a number, who have not had definitive investigations, had at least moderately elevated transaminase levels. In addition to hepatic congestion, transfusion-related hepatitis, particularly hepatitis C, should be considered as a cause of elevated transaminase levels. Abnormal coagulation factors, particularly the procoagulation factor protein C, have been reported after the Fontan operation. ²⁰ To our knowledge, a high prevalence of abnormal prothrombin times has not been reported. This finding may be related to hepatic dysfunction resulting from chronic congestion and carries important clinical implications; care should be taken when administering medication that requires hepatic metabolism and especially when titrating warfarin for anticoagulation.

Limitations.
This cross-sectional review documents the functional state of a large number of patients who underwent the Fontan operation between 1973 and 1991 and survived with an intact circulation. Those in whom the Fontan repair failed before the cross-sectional review are not included in the current analysis but are the subject of a separate report. ⁵ It is possible that outcomes in this study may not reflect the expected long-term results in those operated on more recently at our institution. Patients now tend to be younger at the time of the Fontan operation and are more likely to have an intermediate bidirectional cavopulmonary shunt. They are therefore less likely to be exposed to long-standing ventricular volume overload. Perhaps most important, the duration of "late" postoperative follow-up remains relatively short. Information gathered over the coming decades will further delineate the progress of this challenging group.

A large number of variables were analyzed with respect to functional outcome. However, operations were performed over several decades, and it was not possible to gather sufficient data relative to factors such as preoperative ventricular hypertrophy or pulmonary artery size that may well affect late outcome. ^17,21 In addition, catheterization and echocardiographic data available at the time of the cross-sectional review were unsuitable for analysis in that they had frequently been collected because of a specific clinical concern. It was therefore not possible to relate factors such as postoperative hemodynamics, ventricular function, or atrioventricular valve regurgitation to functional outcome.

Conclusions

At a mean follow-up of 5.4 years after the Fontan operation, more than 90% of patients are satisfied with their overall health and quality of life. Catch-up growth occurs after the Fontan operation, but height and weight are less than in the normal population. Furthermore, late reintervention, medication use, and liver function abnormalities are prevalent. Functional state may deteriorate with increasing duration of follow-up, but the cause of this phenomenon is not clear.

Appendix:

We thank Drs. Aldo R. Castaneda, Richard A. Jonas, William I. Norwood, and Frank L. Hanley, who operated on many of these patients, and Dr. James E. Lock for his critical review of the manuscript. We also thank the referring cardiologists for their assistance with patient contact and their provision of follow-up information. Finally, we thank Jocelyn Wise, Andrea Fishberger, and Mary Dwyer for their assistance with patient follow-up and data management.

Footnotes

From the Departments of Cardiology^a and Cardiac Surgery,^b Children's Hospital, Boston, and the Departments of Paediatrics and Surgery, Harvard Medical School, Boston, Mass.

*Current address: Department of Cardiology, Green Lane Hospital, Auckland, New Zealand.

**Current address: Division of Pediatric Cardiology, Mount Sinai Hospital, New York, N.Y.

***Current address: Division of Pediatric Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pa.

References

1. Mair DD, Hagler DJ, Julsrud PR, Puga FJ, Schaff HV, Danielson GK. Early and late results of the modified Fontan procedure for double-inlet left ventricle: the Mayo Clinic experience. J Am Coll Cardiol 1991;18:1727-32. [Abstract]
   
2. Mair DD, Hagler DJ, Puga FJ, Schaff HV, Danielson GK. Fontan operation in 176 patients with tricuspid atresia: results and a proposed new index for patient selection. Circulation 1990;82(Suppl):1V164-9.
   
3. Mayer JE Jr, Helgason H, Jonas RA, et al. Extending the limits for modified Fontan procedures. J Thorac Cardiovasc Surg 1986;92:1021-8. [Abstract]
   
4. Mayer JE Jr, Bridges ND, Lock JE, Hanley FL, Jonas RA, Castaneda AR. Factors associated with marked reduction in mortality for Fontan operations in patients with single ventricle. J Thorac Cardiovasc Surg 1992;103:444-51. [Abstract]
   
5. Gentles TL, Mayer JE Jr, Gauvreau K, et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg. In press.
   
6. Fontan F, Kirklin JW, Fernandez G, et al. Outcome after a "perfect" Fontan operation. Circulation 1990;81:1520-36. [Abstract/Free Full Text]
   
7. Driscoll DJ, Offord KP, Feldt RH, Schaff HV, Puga FJ, Danielson GK. Five-to fifteen-year follow-up after the Fontan operation. Circulation 1992;85:469-96. [Abstract/Free Full Text]
   
8. Driscoll DJ, Danielson GK, Puga FJ, Schaff HV, Heise CT, Staats BA. Exercise tolerance and cardiorespiratory response to exercise after the Fontan operation for tricuspid atresia or functional single ventricle. J Am Coll Cardiol 1986;7:1087-94. [Abstract]
   
9. Weber HS, Hellenbrand WE, Kleinman CS, Perlmutter RA, Rosenfeld LE. Predictors of rhythm disturbances and subsequent morbidity after the Fontan operation. Am J Cardiol 1989;64:762-7. [Medline]
   
10. Fishberger SB, Wernovsky G, Gentles TL, Gauvreau K, Burnett J, Mayer JE Jr, Walsh EP. Factors influencing the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg 1997;113:80-6. [Abstract/Free Full Text]
    
11. du Plessis AJ, Chang AC, Wessel DL, et al. Cerebrovascular accidents following the Fontan operation. Pediatr Neurol 1995;12:230-6. [Medline]
    
12. Hess J, Kruizinga K, Bijleveld CMA, Hardjowijono R, Eygelaar A. Protein-losing enteropathy after Fontan operation. J Thorac Cardiovasc Surg 1984;88:606-9. [Abstract]
    
13. Fishberger SB, Wernovsky G, Gentles TL, et al. Long-term outcome in Fontan patients with pacemakers. Am J Cardiol 1996;77:887-9. [Medline]
    
14. Jonas RA, Castaneda AR. Modified Fontan procedure: atrial baffle and systemic venous to pulmonary artery anastomotic techniques. J Card Surg 1988;3:91-6. [Medline]
    
15. Mair DD, Puga FJ, Danielson GK. Late functional status of survivors of the Fontan procedure performed during the 1970s. Circulation 1992;86(Suppl):II106-9.
    
16. Nir A, Driscoll DJ, Mottram CD, et al. Cardiorespiratory response to exercise after the Fontan operation: a serial study: J Am Coll Cardiol 1993;22:216-20. [Abstract]
    
17. Kirklin JK, Blackstone EH, Kirklin JW, Pacifico AD, Bargeron LM Jr. The Fontan operation: ventricular hypertrophy, age, and date of operation as risk factors. J Thorac Cardiovasc Surg 1986;92:1049-64. [Abstract]
    
18. Bridges ND, Lock JE, Mayer JE Jr, Burnett J, Castaneda AR. Cardiac catheterization and test occlusion of the interatrial communication after the fenestrated Fontan operation. J Am Coll Cardiol 1995;25:1712-7. [Abstract]
    
19. Wernovsky G, Stiles KM, Gauvreau K, du Plessis AJ, Walsh AZ, Gentles TL, et al. Cognitive development following the Fontan operation [abstract]. Circulation 1995;92(Suppl):I121.
    
20. Cromme-Dijkhuis AH, Hess J, Hahlen K, et al. Specific sequelae after the Fontan operation at mid-and long-term follow-up. J Thorac Cardiovasc Surg 1993;106:1126-32. [Abstract]
    
21. Fontan F, Fernandez G, Costa F, Naftel DC, Tritto F, Blackstone EH, et al. The size of the pulmonary arteries and the results of the Fontan operation. J Thorac Cardiovasc Surg 1989;98:711-9.[Abstract]
    

This article has been cited by other articles:

				G. Wernovsky The Paradigm Shift Toward Surgical Intervention for Neonates With Hypoplastic Left Heart Syndrome Arch Pediatr Adolesc Med, September 1, 2008; 162(9): 849 - 854. [Full Text] [PDF]

				S.-J. Kim, W.-H. Kim, H.-G. Lim, and J.-Y. Lee Outcome of 200 patients after an extracardiac Fontan procedure J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 108 - 116. [Abstract] [Full Text] [PDF]

				A. Giardini, A. Balducci, S. Specchia, G. Gargiulo, M. Bonvicini, and F. M. Picchio Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients Eur. Heart J., July 1, 2008; 29(13): 1681 - 1687. [Abstract] [Full Text] [PDF]

				R. J. Sommer, Z. M. Hijazi, and J. F. Rhodes Pathophysiology of Congenital Heart Disease in the Adult: Part III: Complex Congenital Heart Disease Circulation, March 11, 2008; 117(10): 1340 - 1350. [Full Text] [PDF]

				H. Laks, D. Marelli, M. Plunkett, and J. Myers Adult Congenital Heart Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1431 - 1464. [Full Text]

				K. N. Vogt, C. Manlhiot, G. Van Arsdell, J. L. Russell, S. Mital, and B. W. McCrindle Somatic Growth in Children With Single Ventricle Physiology: Impact of Physiologic State J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1876 - 1883. [Abstract] [Full Text] [PDF]

				M. Ono, D. Boethig, H. Goerler, M. Lange, M. Westhoff-Bleck, and T. Breymann Somatic development long after the Fontan operation: factors influencing catch-up growth. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1199 - 1206. [Abstract] [Full Text] [PDF]

				C. Schreiber, J. Horer, M. Vogt, J. Cleuziou, Z. Prodan, and R. Lange Nonfenestrated Extracardiac Total Cavopulmonary Connection in 132 Consecutive Patients Ann. Thorac. Surg., September 1, 2007; 84(3): 894 - 899. [Abstract] [Full Text] [PDF]

				C. E. Canter, R. E. Shaddy, D. Bernstein, D. T. Hsu, M. R.K. Chrisant, J. K. Kirklin, K. R. Kanter, R. S.D. Higgins, E. D. Blume, D. N. Rosenthal, et al. Indications for Heart Transplantation in Pediatric Heart Disease: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation, February 6, 2007; 115(5): 658 - 676. [Abstract] [Full Text] [PDF]

				M. Ono, D. Boethig, H. Goerler, M. Lange, M. Westhoff-Bleck, and T. Breymann Clinical outcome of patients 20 years after Fontan operation -- effect of fenestration on late morbidity Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 923 - 929. [Abstract] [Full Text] [PDF]

				H. Senzaki, S. Masutani, H. Ishido, M. Taketazu, T. Kobayashi, N. Sasaki, H. Asano, T. Katogi, S. Kyo, and Y. Yokote Cardiac Rest and Reserve Function in Patients With Fontan Circulation J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2528 - 2535. [Abstract] [Full Text] [PDF]

				S. Giannico, F. Hammad, A. Amodeo, G. Michielon, F. Drago, A. Turchetta, R. Di Donato, and S. P. Sanders Clinical Outcome of 193 Extracardiac Fontan Patients: The First 15 Years J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2065 - 2073. [Abstract] [Full Text] [PDF]

				M. E. Mitchell, R. F. Ittenbach, J. W. Gaynor, G. Wernovsky, S. Nicolson, and T. L. Spray Intermediate outcomes after the Fontan procedure in the current era J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 172 - 180. [Abstract] [Full Text] [PDF]

				U. Fakler, C. Pauli, M. Hennig, W. Sebening, and J. Hess Assumed oxygen consumption frequently results in large errors in the determination of cardiac output J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 272 - 276. [Abstract] [Full Text] [PDF]

				M. N. Kavarana, S. Pagni, M. R. Recto, W. L. Sobczyk, T. Yeh Jr, M. Mitchell, and E. H. Austin III Seven-Year Clinical Experience With the Extracardiac Pedicled Pericardial Fontan Operation Ann. Thorac. Surg., July 1, 2005; 80(1): 37 - 43. [Abstract] [Full Text] [PDF]

				J. H. Nurnberg, S. Ovroutski, V. Alexi-Meskishvili, P. Ewert, R. Hetzer, and Peter. E. Lange New Onset Arrhythmias After the Extracardiac Conduit Fontan Operation Compared With the Intraatrial Lateral Tunnel Procedure: Early and Midterm Results Ann. Thorac. Surg., December 1, 2004; 78(6): 1979 - 1988. [Abstract] [Full Text] [PDF]

				M. I. Cohen, L. A. Rhodes, T. L. Spray, and J. W. Gaynor Efficacy of prophylactic epicardial pacing leads in children and young adults Ann. Thorac. Surg., July 1, 2004; 78(1): 197 - 202. [Abstract] [Full Text] [PDF]

				J. Weipert, C. Noebauer, C. Schreiber, M. Kostolny, B. Zrenner, A. Wacker, J. Hess, and R. Lange Occurrence and management of atrial arrhythmia after long-term Fontan circulation J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 457 - 464. [Abstract] [Full Text] [PDF]

				T. J. Bradley, D. G. Human, J.A. G. Culham, W. J. Duncan, M. W. H. Patterson, J. G. LeBlanc, and S. S. Sett Clipped tube fenestration after extracardiac Fontan allows for simple transcatheter coil occlusion Ann. Thorac. Surg., December 1, 2003; 76(6): 1923 - 1928. [Abstract] [Full Text] [PDF]

				J. R. Lee, J. S. Choi, C. H. Kang, E. J. Bae, Y. J. Kim, and J. R. Rho Surgical results of patients with a functional single ventricle Eur. J. Cardiothorac. Surg., November 1, 2003; 24(5): 716 - 722. [Abstract] [Full Text] [PDF]

				S. P. Kumar, C. S. Rubinstein, J. M. Simsic, A. B. Taylor, J. P. Saul, and S. M. Bradley Lateral tunnel versus extracardiac conduit fontan procedure: a concurrent comparison Ann. Thorac. Surg., November 1, 2003; 76(5): 1389 - 1397. [Abstract] [Full Text] [PDF]

				J. Elefteriades, C. Lovoulos, R. Edwards, S. Tittle, T. Riley, P. Tang, E. Rocco, and G. Kopf Novel technique for isolated accessory right heart transplantation for congenital heart disease J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1283 - 1290. [Abstract] [Full Text] [PDF]

				H. Laks, D. Marelli, M. Plunkett, J. Odim, and J. Myers Adult Congenital Heart Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1329 - 1358. [Full Text]

				G. Stellin, V.L. Vida, O. Milanesi, M. Rubino, M.A. Padalino, S. Secchieri, G. Pittarello, and D. Casarotto Surgical treatment of complex cardiac anomalies: the 'one and one half ventricle repair' Eur. J. Cardiothorac. Surg., December 1, 2002; 22(6): 1043 - 1049. [Abstract] [Full Text] [PDF]

				R. Kaulitz, G. Ziemer, T. Paul, M. Peuster, H. Bertram, and G. Hausdorf Fontan-type procedures: residual lesions and late interventions Ann. Thorac. Surg., September 1, 2002; 74(3): 778 - 785. [Abstract] [Full Text] [PDF]

				G. Stellin, V.L. Vida, O. Milanesi, M. Rubino, M.A. Padalino, S. Secchieri, G. Pittarello, and D. Casarotto Surgical treatment of complex cardiac anomalies: the 'one and one half ventricle repair' Eur. J. Cardiothorac. Surg., September 1, 2002; 22(3): 431 - 437. [Abstract] [Full Text] [PDF]

				H. Senzaki, S. Masutani, J. Kobayashi, T. Kobayashi, N. Sasaki, H. Asano, S. Kyo, Y. Yokote, and A. Ishizawa Ventricular Afterload and Ventricular Work in Fontan Circulation: Comparison With Normal Two-Ventricle Circulation and Single-Ventricle Circulation With Blalock-Taussig Shunts Circulation, June 18, 2002; 105(24): 2885 - 2892. [Abstract] [Full Text] [PDF]

				F. Lacour-Gayet, C. Haun, K. Ntalakoura, E. Belli, L. Houyel, P. Marcsek, F. Wagner, and J. Weil Biventricular repair of double outlet right ventricle with non-committed ventricular septal defect (VSD) by VSD rerouting to the pulmonary artery and arterial switch Eur. J. Cardiothorac. Surg., June 1, 2002; 21(6): 1042 - 1048. [Abstract] [Full Text] [PDF]

				B. Voss, F.-U. Sack, W. Saggau, S. Hagl, and R. Lange Atrial cardiomyoplasty in a Fontan circulation Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 780 - 786. [Abstract] [Full Text] [PDF]